# CHLORPROMAZINE HYDROCHLORIDE
> **ANDA216724** · Abbreviated New Drug Application (Generic) · Sponsor: THINQ PHARM-CRO PVT · Approved 2024-12-10
## Drug
- **FDA Application Number:** ANDA216724
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHLORPROMAZINE HYDROCHLORIDE
- **Generic name:** CHLORPROMAZINE HYDROCHLORIDE
- **Active ingredients:** CHLORPROMAZINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** THINQ PHARM-CRO PVT
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2024-12-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216724)
---
*MORVS · CC0 1.0*